* More than 35 years of experience* Consultant Urological Surgeon, Oxford University Hospitals NHS Foundation Trust (1998 - present) * Consultant Urological Surgeon, Nuffield Health The Manor Hospital, Oxford (present)* Consultant Urological Surgeon, Churchill Hospital, Oxford (present)* Chairman, Urology Tumour site-specific group, Thames Valley Cancer Network (2008 - 2013) ...

* FRCS (Urol), Combined Royal Colleges of Surgeons of the UK and Ireland (1997)* Doctor of Medicine, University of Bristol (1993) * MB BS (hons), University of London (1986)* BSc, University of London (1983) ...

* Full Member of BAUS (British Association of Urological Surgeons) and AUA (American Urological Associations)

* Elected executive board member, British Association of Urological Surgeons (2010 - 2015)* Executive board member, European Association of Urology (2008 - 2013)

* More Men Die with Prostate cancer than Because of it €“ An Old Adage that Still Holds True in the 21st Century. Jacklin C, Philippou Y, Brewster SF and Bryant RJ. Cancer Treatment and Research Communications (2021) 26: 1-9. Doi.org/10.1016/j.ctarc.2020.100225.* COMPARISON OF PROSTATE BIOPSY WITH OR WITHOUT PRE-BIOPSY MPMRI FOR PROSTATE CANCER DETECTION: AN OBSERVATIONAL COHORT STUDY Bryant RJ , Hobbs CP, Eyre KS, Davies LC, McCormick R, Sullivan ME, Shields W, Verrill C, Gleeson F, MacPherson R, Hamdy FC , Brewster SF. J Urol 2019; 201: 510-519. Includes an Editorial Comment and Reply by the authors. * OVERCOMING DIFFICULTIES WITH EQUIPOISE TO ENABLE RECRUITMENT TO A RANDOMISED TRIAL OF PARTIAL ABLATION VS RADICAL PROSTATECTOMY FOR UNILATERAL LOCALISED PROSTATE CANCER Elliott D, Hamdy FC, Leslie T, Rosario D, Dudderidge T, Hindley R, Emberton M, Brewster S, Sooriakumaran P, Catto J, Emara A, Ahmed H, Whybrow P, lc Conte S, Donovan J. BJUI 2018; 122: 970-7.* EFFECTS OF INTRODUCING PRE-BIOPSY MPMRI INTO CONTEMPORARY UK PROSTATE CANCER DETECTION C. Hobbs, K. Eyre, R. Mccormick, Hamdy FC, Brewster SF, Bryant R European Urology Supplements 2018 17(2):e1870.* DOES THE INTRODUCTION OF PROSTATE MULTIPARAMETRIC MRI INTO ACTIVE SURVEILLANCE OF LOCALISED PROSTATE CANCER IMPROVE PATIENT RE€CLASSIFICATION? RJ Bryant, B Yang, Y Philippou, K Lam, M Obiakor, J Ayers, V Chiocchia, F Gleeson, R MacPherson, C Verrill, P Sooriakumaran, FC Hamdy, SF Brewster BJUI 2018 ; 122 : 794-800. (Awarded €œArticle of the Week€ by the editor, 18/11/18)* HIGH LEVELS OF PATIENT SATISFACTION IN JOINT URO-ONCOLOGY CLINICS TO ASSIST PATIENT CHOICE IN EARLY PROSTATE CANCER AND MUSCLE- INVASIVE BLADDER CANCER. Kiltie AE, Southby R, LeMonnier K, Binnee J, Niederer J, Kartsonaki C, Camilleri P, Sabharwal A, Brewster S, Crew J, Hamdy FC. Clin Oncol (R Coll Radiol). 2018; 30; e39.* REDUCING MORTALITY IN THE AGEING PATIENT: TREATMENT OF THE PRIMARY TUMOUR IS NOT NECESSARY. Lamb AD, Brewster SF, Hamdy FC. European Urology Focus 2018; 3, 328-329.* MANAGING PATIENTS WITH METASTATIC PROSTATE CANCER: WHO TAKES THE LEAD? Hughes, S, McNeill A, Brewster S, Clarke N, Troup J and Payne H. Health Trends 2017; 8: 25-30.* INTRODUCING MPMRI INTO CONTEMPORARY UK ACTIVE SURVEILLANCE FOR LOCALISED PROSTATE CANCER. Bryant Rj, Yang B, Philippou Y, Lam K, Obiakor M, Ayers J, Gleeson F, Macpherson R, Verrill C, Roberts I, Leslie T, Crew J, Sooriakumaran P, Hamdy Fc, Brewster S. J Urol 2017;197:No. 4S, e1054.* ADVANCES IN UROLOGY 2015-2016. Brewster S, Biers S, Challacombe B, Cresswell J, Sinclair A and Smith D. J Clin Urol 2017; 10: 39-48.* PROSTATE BIOPSY €“ WHAT IS THE MOST APPROPRIATE APPROACH? Richard Bryant and Simon Brewster. BJUI Knowledge 2016 https://app.tessello.co.uk/CourseStore/clients/BJUI/71712 Prostatebiopsywhatistheappropr-2016113141647/launch.html Doi: 10.18591/BJUIK.0184* UROLOGICAL RECOMMENDATIONS FROM THE NICE GUIDELINE, JUNE 2015: SUSPECTED CANCER: RECOGNITION AND REFERRAL Jefferies ER and Brewster SF on behalf of the BAUS Section of Oncology. BJUI 2016; 117: 857-860. doi: 10.1111/bju.13355.* ALTERED EXPRESSION OF MARKERS OF EPITHELIAL-TO-MESENCHYMAL TRANSITION AT THE EXTRAPROSTATIC EXTENSION COMPONENT OF LOCALLY INVASIVE PROSTATE CANCERS Verrill C., Schmitt AJ, Roberts ID, Gill S P,Browning L , Brewster SF, Hamdy FC, Bryant RJ. Oncotarget 2016; 7: 1107€“1119.* ESTABLISHING NURSE-LED ACTIVE SURVEILLANCE FOR MEN WITH LOCALISED PROSTATE CANCER: DEVELOPMENT AND FORMATIVE EVALUATION OF A MODEL OF CARE IN THE PROTECT TRIAL. Julia Wade, Peter N Holding, Susan Bonnington, Leila Rooshenas, J Athene Lane, C Elizabeth Salter, Kate Tilling, Mark J Speakman, Simon F Brewster, Simon Evans, David E Neal, Freddie C Hamdy, Jenny L Donovan For The Protect Study Group. BMJ Open 2015; 5:e008953.doi:10.1136/bmjopen-2015-008953 22 Sept 2015 ...

* Elected Clinical Staff Governor, Oxford University Hospitals NHS Foundation Trust (2017-present)

* Lecturer, University of Oxford Clinical (1998 - present)* Fellow and clinical tutor, Hertford College, Oxford (2002 - present) * Teaching departmental lead; weekly 1-hour tutorials, University of Oxford Clinicial (1998 - present) ...